Cottu P - Search Results

1

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer.

Cottu P, D'Hondt V, Dureau S, Lerebours F, Desmoulins I, Heudel PE, Duhoux FP, Levy C, Mouret-Reynier MA, Dalenc F, Frenel JS, Jouannaud C, Venat-Bouvet L, Nguyen S, Ferrero JM, Canon JL, Grenier J, Callens C, Gentien D, Lemonnier J, Vincent-Salomon A, Delaloge S. Cottu P, et al. Ann Oncol. 2018 Dec 1;29(12):2334-2340. doi: 10.1093/annonc/mdy448. Ann Oncol. 2018. PMID: 30307466 Free article. Clinical Trial.

2

Prospects with docetaxel in the treatment of patients with breast cancer.

Marty M, Extra JM, Cottu PH, Espié M. Marty M, et al. Among authors: cottu ph. Eur J Cancer. 1997 Aug;33 Suppl 7:S26-9. doi: 10.1016/s0959-8049(97)90007-1. Eur J Cancer. 1997. PMID: 9486101 Review.

3

[Clinical activity spectrum of irinotecan].

Cottu PH, Extra JM, Lerebours F, Espie M, Marty M. Cottu PH, et al. Bull Cancer. 1998 Dec;Spec No:21-5. Bull Cancer. 1998. PMID: 9932080 Free article. Review. French.

4

Optimizing chemotherapy for patients with advanced breast cancer.

Marty M, Espie M, Cottu PH, Cuvier C, Lerebours F. Marty M, et al. Among authors: cottu ph. Oncology. 1999 Jul;57 Suppl 1:21-6. doi: 10.1159/000055265. Oncology. 1999. PMID: 10436413 Review.

5

High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patients.

Cottu PH, Zelek L, Extra JM, Espie M, Mignot L, Morvan F, Marty M. Cottu PH, et al. Ann Oncol. 1999 Jul;10(7):795-801. doi: 10.1023/a:1008353904351. Ann Oncol. 1999. PMID: 10470426 Free article. Clinical Trial.

6

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Delaloge S, Yovine A, Taamma A, Riofrio M, Brain E, Raymond E, Cottu P, Goldwasser F, Jimeno J, Misset JL, Marty M, Cvitkovic E. Delaloge S, et al. Among authors: cottu p. J Clin Oncol. 2001 Mar 1;19(5):1248-55. doi: 10.1200/JCO.2001.19.5.1248. J Clin Oncol. 2001. PMID: 11230465 Clinical Trial.

7

[Oxaliplatin: perspectives and future developments].

Marty M, Cottu PH, Lerebours F, Bedairia N, Hocini H, Espié M. Marty M, et al. Among authors: cottu ph. Bull Cancer. 2001 Aug;88 Spec No:S5-8. Bull Cancer. 2001. PMID: 11567907 French. No abstract available.

8

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.

Cottu PH, Extra JM, Espie M, Marolleau JP, de Roquancourt A, Makke J, Miclea JM, Laurence V, Mayeur D, Lerebours F, Cuvier C, Marty M. Cottu PH, et al. Br J Cancer. 2001 Nov 2;85(9):1240-6. doi: 10.1054/bjoc.2001.2069. Br J Cancer. 2001. PMID: 11720455 Free PMC article. Clinical Trial.

9

Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.

Zelek L, Cottu P, Tubiana-Hulin M, Vannetzel JM, Chollet P, Misset JL, Chouaki N, Marty M, Gamelin E, Culine S, Dieras V, Mackenzie S, Spielmann M. Zelek L, et al. Among authors: cottu p. J Clin Oncol. 2002 May 15;20(10):2551-8. doi: 10.1200/JCO.2002.06.164. J Clin Oncol. 2002. PMID: 12011135 Clinical Trial.

10

High-dose adjuvant chemotherapy for breast cancer: state of the art.

Cottu PH, Cuvier C, Espié M. Cottu PH, et al. Forum (Genova). 2002;12(1):36-40. Forum (Genova). 2002. PMID: 12634909 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters